Premium
Rapid remission with calcipotriol betamethasone in refractory Fox–Fordyce disease
Author(s) -
Yang Lu,
Zhang Shiyu,
Wang Tao,
He Zhixin,
Liu Yuehua,
Zdravković Tanja Prunk
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13223
Subject(s) - medicine , intertriginous , dermatology , calcipotriol , axilla , refractory (planetary science) , umbilicus (mollusc) , perineum , apocrine , betamethasone , antiandrogens , etiology , disease , surgery , psoriasis , pathology , androgen , physics , astrobiology , antiandrogen , cancer , breast cancer , hormone
Fox–Fordyce disease (FFD) is a rare pruritic dermatosis whose etiology has not been fully explored. It is mostly seen in women and presents as pruritic follicular papules at the apocrine (gland‐bearing) regions, including the axilla, groins, perineum, and areola mammae, as well as the umbilicus. Treatment for FFD is extremely challenging in that there is no curative treatment for it. We report the case of a 26‐year‐old woman who was refractory to many treatments but who responded to calcipotriol betamethasone with rapid remission of her symptoms.